Patent · US Active

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

US11413274B2 · kind B2 · utility

0Cited by

5References

8Claims

0Family size

Assignee

Ligand Pharmaceuticals Incorporated · US

Inventors

Lin Zhi · San Diego, US
Keith Marschke · San Diego, US
Virginia Heather Sharron Grant · San Diego, US
Steven L. Roach · San Diego, US
Yixing Shen · Encinitas, US
Jason C. Pickens · San Diego, US
Bijan Pedram · San Diego, US
Cornelis Arjan Van Oeveren · Carlsbad, US
Lino Valdez · Carlsbad, US
Andrew R. Hudson · San Diego, US

Key dates

Filing date	Jul 10, 2020
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Jul 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/66
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Some embodiments include compositions and methods of using or identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Some embodiments include use of compounds to treat certain disorders, such as hematopoietic or neurological disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.